XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENT REPORTING (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | The following table presents a summary of the revenues and Adjusted EBITDA of our two operating segments for the three and six months ended June 30, 2025 and 2024:
| Three Months Ended June 30, |  | Six Months Ended June 30,
(In thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Revenues: |  |  |  |  |  |  |
Financial Health | $ | 54,284 |  |  | $ | 54,509 |  |  | $ | 110,417 |  |  | $ | 107,948 |
Patient Care | 31,445 |  |  | 31,091 |  |  | 62,520 |  |  | 61,769 |
Total revenues | 85,729 |  |  | 85,600 |  |  | 172,937 |  |  | 169,717 |
Less: |  |  |  |  |  |  |
Financial Health expenses: |  |  |  |  |  |  |
Cost of revenues (excluding amortization and depreciation and stock compensation expense) | $ | 28,842 |  |  | $ | 30,162 |  |  | $ | 55,915 |  |  | $ | 59,685 |
Product development (excluding stock compensation) | 3,002 |  |  | 1,904 |  |  | 6,111 |  |  | 4,331 |
Sales and marketing (excluding stock compensation) | 5,029 |  |  | 5,012 |  |  | 8,859 |  |  | 9,295 |
General and administrative expenses (excluding stock compensation) | 10,319 |  |  | 9,222 |  |  | 21,159 |  |  | 19,631 |
Total Financial Health expenses | $ | 47,192 |  |  | $ | 46,300 |  |  | $ | 92,044 |  |  | $ | 92,942 |
Patient Care expenses: |  |  |  |  |  |  |
Cost of revenues (excluding amortization and depreciation and stock compensation expense) | $ | 11,790 |  |  | $ | 12,950 |  |  | $ | 24,031 |  |  | $ | 25,152 |
Product development (excluding stock compensation) | 4,868 |  |  | 6,048 |  |  | 9,798 |  |  | 14,097 |
Sales and marketing (excluding stock compensation) | 2,784 |  |  | 2,592 |  |  | 4,179 |  |  | 4,763 |
General and administrative expenses (excluding stock compensation) | 5,352 |  |  | 4,266 |  |  | 10,911 |  |  | 8,995 |
Total Patient Care expenses | $ | 24,794 |  |  | $ | 25,856 |  |  | $ | 48,919 |  |  | $ | 53,007 |
Total segment expenses | $ | 71,986 |  |  | $ | 72,156 |  |  | $ | 140,963 |  |  | $ | 145,949 |
Adjusted EBITDA by segment: |  |  |  |  |  |  |
Financial Health | 7,092 |  |  | 8,209 |  |  | 18,373 |  |  | 15,006 |
Patient Care | 6,651 |  |  | 5,235 |  |  | 13,601 |  |  | 8,762 |
Total Adjusted EBITDA | $ | 13,743 |  |  | $ | 13,444 |  |  | $ | 31,974 |  |  | $ | 23,768 |
Schedule of Reconciliation of Adjusted EBITDA to Income (Loss) Before Taxes | The following table reconciles Adjusted EBITDA to income (loss) before taxes:
| Three Months Ended June 30, |  | Six Months Ended June 30,
(In thousands) | 2025 |  | 2024 |  | 2025 |  | 2024
Total Adjusted EBITDA | $ | 13,743 |  |  | $ | 13,444 |  |  | $ | 31,974 |  |  | $ | 23,768 |
Less: |  |  |  |  |  |  |
Interest expense and other income | 2,929 |  |  | 4,151 |  |  | 6,340 |  |  | 8,051 |
Depreciation expense | 312 |  |  | 400 |  |  | 603 |  |  | 800 |
Amortization of software development costs | 3,245 |  |  | 5,980 |  |  | 6,316 |  |  | 8,722 |
Amortization of acquisition-related intangibles | 3,046 |  |  | 3,126 |  |  | 6,098 |  |  | 6,253 |
Stock-based compensation | 2,097 |  |  | 1,501 |  |  | 3,310 |  |  | 2,300 |
Severance and other non-recurring charges | 1,416 |  |  | 4,586 |  |  | 3,860 |  |  | 8,430 |
Gain on disposal of property and equipment | — |  |  | — |  |  | (120) |  |  | — |
Gain on sale of AHT | — |  |  | — |  |  | (53) |  |  | (1,250) |
Income (loss) before taxes | $ | 698 |  |  | $ | (6,300) |  |  | $ | 5,620 |  |  | $ | (9,538) |

X
- Definition Reconciliation Of Net Income From Continuing Operations To Adjusted Income (Loss) From Before Interest, Taxes, Depreciation And Amortization + References No definition available. + Details
Name: | tbrg_ReconciliationOfNetIncomeFromContinuingOperationsToAdjustedIncomeLossFromBeforeInterestTaxesDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | tbrg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration